SURMOUNT-5: Tirzepatide and semaglutide go head-to-head in battle of weight loss drugsEli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the company’s tirzepatide (Mounjaro)...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure22 hours ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity22 hours ago